Skip to main content

Anna Bonaterra Pastra

Postdoctoral researcher in the neurovascular diseases group at VHIR. Interested in cerebral hemorrhagic lesions, Alzheimer's Disease and Cerebral Amyloid Angiopathy. Also studying lipoprotein and apolipoprotein functions and roles in these diseases.

Institutions of which they are part

Postdoctoral researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Anna Bonaterra Pastra

Institutions of which they are part

Postdoctoral researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Postdoctoral researcher in the neurovascular diseases group at VHIR. Interested in cerebral hemorrhagic lesions, Alzheimer's Disease and Cerebral Amyloid Angiopathy. Also studying lipoprotein and apolipoprotein functions and roles in these diseases.

Currently performing biomedical research in the neurovascular diseases group.
PhD in Neuroscience (UAB).
Màster in Translational Biomedical Research (UAB, Barcelona).
University degree in Biomedicine (UB, Barcelona). Internship at VRIJE University (Amsterdam) CNCR.

Projects

Implicaction of proteins associated with vascular beta-amyloid in Cerebral Amyloid Angiopathy

IP: Maria Mar Hernandez Guillamon
Collaborators: Marcel Lamana Vallverdu, Anna Bonaterra Pastra, Jessica Camacho Soriano, Olga Maisterra Santos, Olalla Pancorbo Rosal
Funding agency: Instituto de Salud Carlos III
Funding: 169400
Reference: PI20/00465
Duration: 01/01/2021 - 30/06/2025

Estudio de la implicación de la distribución de la apolipoproteína J (ApoJ/Clusterin) en lipoproteínas circulantes en la Angiopatía Amiloide Cerebral

IP: Maria Mar Hernandez Guillamon
Collaborators: Anna Bonaterra Pastra, Guillem Colell Dinares, David Rodriguez Luna
Funding agency: Instituto de Salud Carlos III
Funding: 110715
Reference: PI17/00275
Duration: 01/01/2018 - 31/12/2020

Related news

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Related professionals

Jorge Pamias Romero

Jorge Pamias Romero

New Technologies and Craniofacial Microsurgery
Read more
Luis Enrique Lara Moctezuma

Luis Enrique Lara Moctezuma

Kidney Physiopathology
Read more
Jorge Leno Colorado

Jorge Leno Colorado

Research technician
Genetics Medicine
Read more
José Manuel Vidal Taboada

José Manuel Vidal Taboada

Main researcher
Peripheral Nervous System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.